Publication in The Lancet

Interesting results of a study in which we participated and co-authored a publication in The Lancet Regional Health-Europe have been published: “An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine” Sputnik Light” for prevention of coronavirus infection in healthy adults”. In this article, for the first time, comparative data on the level of antibodies in groups of naive subjects and those who were previously infected with COVID-19 were shown.

Link to the full article: